TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.

Lawrence G Lum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.